Lidocaine in status epilepticus.
School of Pharmacy, University of California, San Francisco.
E
E
Teng
P
P
Wilkins
D006801:Humans; D007262:Infusions, Intravenous; D008012:Lidocaine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010672:Phenytoin / Q000627:therapeutic use; D012008:Recurrence; D013226:Status Epilepticus / Q000188:drug therapy*
D010672:Phenytoin; D008012:Lidocaine